Isolates of Borrelia burgdorferi, the causative agent of Lyme disease, express up to 5 distinct complement regulator-acquiring surface proteins (CRASP-1, -2, -3, -4, and -5).
tem, and the skin, thereby causing Lyme arthritis, neuroborreliosis, or acrodermatitis chronica atrophicans [1] . Upon infection, complement, which represents the first line of innate immune defense, is activated. One central strategy of B. burgdorferi to avoid a destructive complement attack is the binding of host fluidphase complement regulators, such as factor H and/or factor H-like protein 1 (FHL-1) to their surface [3, 4] . Acquisition of these host proteins allows innate immune control and inhibition of the complement cascade at the level of C3 directly on the surface of the pathogen [4] .
Factor H and FHL-1, the main human fluid-phase regulators of the alternative pathway of complement, are structurally related and are both encoded by the factor H gene, which is located on chromosome band 1q32 [5] . In their secreted forms, the 2 plasma proteins are exclusively composed of individual protein domains Figure 1 . Absorption of host immune regulators from human and mouse serum. Borrelia burgdorferi strain LW2 bacteria were incubated in human (A and B) or mouse (C) serum or with purified proteins (D). After extensive washing, bound proteins were eluted, separated by SDS-PAGE, and identified by Western blotting using specific antibody or antiserum. Panel A shows that monoclonal antibody VIG8 reacted with the C-terminus of factor H and with factor H-related protein 1 (FHR-1). Panel B shows that anti-SCR1-4 reacted with the N-terminus of factor H and identifies factor H and factor H-like protein 1 (FHL-1). In panel C, factor H antiserum that reacts with mouse factor H and with the 2 FHR proteins present in mouse serum was used. In panel D, Borrelia cells were incubated with either recombinant human FHR-1, purified human factor H, or recombinant human FHL-1. Bound proteins were identified in the elute fraction with specific antiserum. The mobility of the marker proteins is indicated.
termed "short consensus repeats" (SCRs). The 42-kDa FHL-1 protein consists of 7 SCRs, and the 150-kDa factor H protein includes 20 SCRs [6] . The SCRs of FHL-1 are identical to the N-terminal domain of factor H; however, the protein has a unique C-terminal extension of 4 aa [7] . Factor H and FHL-1 are members of the factor H protein family, which in humans includes 6 additional factor H-related proteins (FHR-1, -2, -3, -4A, -4B, and -5) [8] . The FHR proteins represent plasma proteins that are structurally and antigenically related to each other and to factor H and that are transcribed from separate genes. The human FHR-1 protein is composed of 5 SCR domains and exists in 2 forms. The 37-kDa FHR-1a has 1 and the 43-kDa FHR-1b has 2 carbohydrate side chains attached [9] . The 3 most C-terminal SCRs of FHR-1 (SCR3, -4, and -5) display a high homology to SCR18, -19, and -20 of factor H, suggesting similar and conserved function(s). The C-terminal SCRs of both FHR-1 and factor H bind to heparin and C3b, which is indicative of a regulatory role in complement activation [10, 11] . The precise function(s) of the FHR proteins is currently under investigation. FHR genes are conserved in evolution and have been identified in humans, chimpanzees, rats, mice, and the bony fish barred sand bass [12, 13] .
Serum-resistant B. afzelii as well as moderately serum-resistant B. burgdorferi strains express surface proteins that bind the human complement regulators factor H and/or FHL-1 [14] . These borrelial lipoproteins are termed "complement regulator-acquiring surface proteins" (CRASPs). CRASPs have been divided into 2 groups: proteins that bind both factor H and FHL-1 (CRASP-1 and -2 of B. afzelii and B. burgdorferi) and proteins that exclusively bind factor H (CRASP-4 and -5 of B. afzelii and CRASP-3, -4, and -5 of B. burgdorferi) [3] . The 5 CRASPs of B. burgdorferi form a functionally related but structurally heterologous group of proteins. The factor H-and FHL-1-binding CRASP-1 belongs to the paralogous family gbb54 Figure 2 . Binding of factor H-related protein 1 (FHR-1) to serum-resistant, but not serum-sensitive, Borrelia burgdorferi strains. Cell lysate prepared from serum-resistant (LW2, B31, ZS7, 297, PKa-1, and N40; lanes 1-6) and serum-sensitive (PBi, PSth, G1, G2, 1/B29, and A87S B ; lanes 7-12) strains was separated by SDS-PAGE, transferred to a membrane, and probed with FHR-1. The mobility of the various complement regulator-acquiring surface proteins (CRASPs) and that of the size markers is indicated.
[15], and CRASP-2, which lacks amino acid homology to any other CRASP, is encoded by a single gene located on lp28-3 [16] . CRASP-3, -4, and -5 are members of the polymorphic Erp (OspE/F-related proteins) family of B. burgdorferi strain B31 [17] , with CRASP-3 corresponding to ErpP, CRASP-4 to ErpC, and CRASP-5 to ErpA [18, 19] . Serum resistance of Borrelia strains correlates with CRASP expression, suggesting that factor H and FHL-1 attach to the microbial surface and regulate complement activation [3, 20] .
In the present study, we have identified FHR-1 as an additional human plasma protein that binds to serum-resistant, but not to serum-sensitive, B. burgdorferi. B. burgdorferi binds to FHR-1 via CRASP-3, -4, and -5. Each of these borrelial surface proteins also binds factor H. The different recognition and binding patterns of the individual CRASPs are relevant for immune evasion.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Serum-resistant B. burgdorferi strains (LW2 [skin isolate, Germany], B31, ZS7, 297, PKa-1, and N40) as well as serum-sensitive strains (PBi, PSth, G1, G2, 1/B29, and A87S B ) were grown at 33ЊC for 5-6 days up to a cell density of cells/mL in modified Barbour- 7 1 ϫ 10 Stoenner-Kelly medium, as described elsewhere [14] .
Expression of recombinant FHR-1 and FHL-1. Recombinant FHR-1 and FHL-1 were expressed in insect cells infected with recombinant baculovirus [7, 11] . Briefly, adherent Spodoptera frugiperda cells (Sf9) grown at 28ЊC in monolayer cultures were infected with recombinant virus at an MOI of 5.
Construction of expression plasmids and purification of CRASPs. Construction and expression of plasmids harboring the cspA, cspZ, and erpP genes encoding for CRASP-1, -2, and -3 was done as described elsewhere [15, 17] . CRASP-4 was amplified using primers ErpC42 (forward; 5 -GCTTTGATAA-GTGGATCCAAAAATCATACTTTATATG-3 ) and ErpC3nc (reverse; 5 -GCTTTTTGATTCATAATTGTTCTCGAGTAT-ACTTCTAAC-3 ) of strain B31-MI [21] . The amplified DNA fragment was digested with restriction enzymes BamHI and XhoI, resulting in a gene lacking the hydrophobic leader-encoding sequences and ligated in frame into the pGEX-6P-1 vector, which includes a glutathione-S-transferase (GST) tag. Similarly, the gene for CRASP-5 was amplified using primers OspE37 (forward; 5 -GTTTTTATACTCCCGGGTGCTTGCA-AAATTCAT-3 ) and ErpA3nc (reverse; 5 -GTTTTTTTATTCA-TATACGGGCCCTCCTATATTTCTAAC-3 ) and were digested with SmaI. The gene lacking the hydrophobic leader sequence was ligated into expression vector pGEX-6P-1. All 5 CRASPs were expressed as GST-fusion proteins in Escherichia coli JM109 and were purified on glutathione-Sepharose, as described elsewhere [17] .
Absorption experiments. Absorption experiments were performed as described elsewhere [14] . Briefly, B. burgdorferi cells ( cells) were grown to mid-log phase, harvested by cen- , and 0.1% gelatine [pH 7.4]). B. burgdorferi strain LW2 was incubated either in normal human serum (NHS), 750 mL of mouse serum, or PBS supplemented with purified FHR-1 (2.5 mg), factor H (2.5 mg; Calbiochem), or FHL-1 (2.5 mg).
Immunofluorescence assay. B. burgdorferi strain LW2, which expresses all 5 CRASPs, was grown to mid-log phase, harvested, washed, and resuspended in 300 mL of PBS. Spirochetes ( ) were incubated with 5 mg of purified FHR-1, factor 8 2 ϫ 10 H, or FHL-1 for 1 h at room temperature. After 4 washes with PBS containing 0.2% BSA (PBSA), cells were collected and resuspended in PBSA. After incubation with polyclonal antiserum specific for the N-terminus of factor H and FHL-1 or monoclonal antibodies (MAbs) specific for the C-terminus of FHR-1 and factor H (VIG8 and C18), cells were washed. Ali- quots of 10 mL were spotted on microscopic slides and allowed to dry overnight. After fixation with acetone, samples were dried at room temperature and incubated in a humidified chamber with secondary Alexa 555-and Alexa 488-labeled antibodies. Slides were then washed with PBSA and mounted on ProLong Gold antifade reagent (Molecular Probes) before being sealed. Slides were visualized by confocal microscopy using an LSM microscope (Carl Zeiss). Protein-binding assays. Recombinant CRASPs (5 mg/mL each) or cell extract prepared from cells expressing an unrelated protein were immobilized on wells of a microtiter plate (MaxiSorb; Nunc) overnight at 4ЊC. After 3 washing steps with PBS containing 0.05% Tween 20, unspecific binding sites were blocked with 0.2% gelatin in PBS for 6 h at 4ЊC. The immobilized proteins were incubated with NHS (diluted 1:10) overnight at 4ЊC. After being washed 3 times in PBS, protein complexes were removed from the well using SDS buffer (60 mmol/ L Tris [pH 6.8], 2% SDS, and 25% glycerin). This mixture was subjected to SDS-PAGE and analyzed by Western blotting using polyclonal rabbit anti-factor H SCR1-4 antiserum [7] or MAb VIG8 [22] .
SDS-PAGE and Western blot analysis. Wash and elute fractions (obtained from the adsorption experiments) or samples obtained from the cofactor assays were separated by SDS-PAGE, and factor H SCR1-4 antiserum or MAb VIG8 or C3b antiserum was used for Western blotting.
ELISA. Recombinant CRASPs (5 mg/mL each) were immobilized on wells of a microtiter plate overnight at 4ЊC. Unspecific binding sites were blocked with 0.2% gelatin in PBS for 6 h at 4ЊC. FHR-1, factor H (Calbiochem), or FHL-1 was added to the wells and left overnight at 4ЊC. After addition of factor H SCR1-4 antiserum or MAb VIG8 for 2 h at room temperature, protein complexes were identified using secondary horseradish peroxidase-coupled antiserum. The reaction was developed with 1,2-phenylenediamine dihydrochloride (DakoCytomation), and absorbency was measured at 490 nm.
Ligand-affinity blotting. Cell extract was prepared from serum-resistant and serum-sensitive Borrelia strains and was analyzed by ligand-affinity blotting, as described elsewhere [16] .
Surface plasmon resonance. Protein-protein interactions were analyzed using surface plasmon resonance with a Biacore 3000 instrument (Biacore AB), as described elsewhere [23] .
Cofactor assay. Cofactor activity of factor H bound to CRASPs was analyzed by measuring factor I-mediated conversion of C3b to inactive C3b (iC3b) [24] .
RESULTS
Binding of FHR proteins derived from human and mouse serum to B. burgdorferi. B. burgdorferi strain LW2 was incubated either in human or mouse serum, and bound proteins were eluted, separated by SDS-PAGE, and analyzed by Western blotting. MAb specific for the common C-terminus of FHR-1 and factor H identified FHR-1a, FHR-1b, and factor H in the elute fraction ( figure 1A, lane 2 ). An antiserum reacting with SCR1-4 identified factor H and FHL-1 ( figure 1B, lane 2) . Because mice represent a common reservoir for B. burgdorferi, mouse serum was used. This approach identified mouse factor H (150 kDa) and 2 murine (m) FHR-proteins, mFHR-C (100 kDa) and mFHR-E (40 kDa), in the elute fraction ( figure 1C,  lane 2) . The results obtained with human serum were confirmed using purified FHR-1, factor H, and FHL-1. All 3 human proteins were detected in the elute fraction ( figure 1D, lanes 2, 4,  and 6 ). These experiments demonstrate binding of FHR proteins from human and mouse sources to borrelial cells.
Correlation between binding of human FHR-1 and serum resistance. To analyze whether FHR-1 binding correlates with serum resistance, serum-resistant and serum-sensitive isolates were used. FHR-1 bound to all lysates prepared from serumresistant strains (LW2, B31, ZS7, 297, PKa-1, and N40) but not from serum-sensitive strains (PBi, PSth, G1, G2, 1/B29, and A87S B ) (figure 2). The serum-resistant strains express several FHR-1 binding proteins, and on the basis of mobility, it can be concluded that binding occurs via CRASP-3, -4, and -5.
Binding of human FHR-1 to intact B. burgdorferi. Immunofluorescence microscopy was used to visualize the distribution on the surface. FHR-1 binding to intact B. burgdorferi strain LW2, which expresses all 5 CRASPs, showed a patchy pattern, indicating a clustering of the borrelial FHR-1 binding surface proteins ( figure 3A) . Bound factor H and FHL-1 showed a more homogenous distribution over the entire bacterial surface ( figure 3B and 3C) . When B. burgdorferi was incubated with human serum, the staining pattern suggested that the proteins bind simultaneously to the borrelial surface ( figure 3D) .
Binding of human serum proteins FHR-1, factor H, and FHL-1 to CRASPs. To identify which CRASP binds FHR-1, a combined ELISA and Western blot assay was used, one that allows the identification of the bound host regulators according to their mobility and reactivity. This assay showed weak binding of FHR-1a and FHR-1b to CRASP-3 and strong binding to CRASP-4 and -5 ( figure 4A, top) . Factor H bound strongly to CRASP-1, -2, and -5 and weakly to CRASP-3 and -4 ( figure  4A, middle) . In addition, FHL-1 did bind to CRASP-1 and -2 (figure 4A, bottom) but to no other CRASP. Thus, FHR-1, factor H, and FHL-1 bind to several CRASPs and show differential preference for individual CRASPs.
Binding was further assayed by ELISA to quantify and compare the intensity of binding. Purified FHR-1 bound weakly to CRASP-3 and -4 and strongly to CRASP-5. Factor H showed prominent binding to CRASP-1, -2, and -5. FHL-1 bound to CRASP-1 and -2 but no other CRASP ( figure 4B) .
Surface plasmon resonance. Having identified FHR-1 as a ligand for CRASP-3, -4, and -5, the binding profiles of FHR-1 and factor H were compared using surface plasmon resonance. FHR-1 bound to CRASP-3, as indicated by the strong association and dissociation profile (figure 5A). FHR-1 binding to CRASP-3 was more pronounced than factor H binding. When equimolar amounts of FHR-1 were used, CRASP-3 interaction was almost twice as strong as factor H interaction. Factor H dissociation was more rapid, and FHL-1 did not bind to CRASP-3. FHR-1 showed strong binding to CRASP-4 (figure 5B). With surface plasmon resonance, binding of neither factor H nor FHL-1 to CRASP-4 was detectable. FHR-1 bound strongly to CRASP-5, as demonstrated by the strong association and the stability of the complex after removal of the ligand (figure 5C). Also, factor H bound to CRASP-5, and dissociation of the factor H:CRASP-5 complex was faster than that of FHR-1:CRASP-5 complex. FHL-1 did not bind to CRASP-5. These assays revealed that FHR-1 binds to 3 CRASPs and that the binding is stronger relative to that of factor H.
The affinity for the strongest associating partners-that is, FHR-1 binding to CRASP-5-was analyzed on a kinetic level. On immobilization of CRASP-5 and using FHR-1 from 0 to 15 nmol, the interaction followed a 1:1 model and reached a dissociation constant of mol/L, with an association Ϫ9 3 ϫ 10 rate of 1/ms and a dissociation rate of 1/s.
Ϫ3
3.8 ϫ 10 1 ϫ 10 When CRASP-3 and -4 were immobilized at the same concentration, the interaction was not sufficient to determine kinetic values. Therefore, the interaction between FHR-1 and each of the 3 CRASPs was compared at higher levels, allowing a relative comparison of the association and dissociation rates. FHR-1 showed the strongest association with CRASP-5, and the association with both CRASP-4 and -3 was ! 1/ 5 3.8 ϫ 10 ms. Similarly, the interaction between FHR-1 and CRASP-3 was the most stable, with a dissociation rate ! 1/s.
1 ϫ 10 Competition between FHR-1 and factor H for CRASP binding. The binding preferences of FHR-1 and factor H to CRASP-3, -4, and -5 were compared. When increasing amounts of FHR-1 and a constant concentration of factor H was used, simultaneous binding of both proteins was detected. Binding of factor H was detected with the factor H-specific MAb B22, and binding of both FHR-1 and factor H was detected with MAb VIG8. For CRASP-3, an increase in the concentration of FHR-1 resulted in decreased reactivity of the factor H-specific MAb and in increased reactivity of MAb VIG8, which reacts with both proteins ( figure 6A ). This pattern shows that CRASP-3 binds both proteins simultaneously. When a ratio reflecting the physiological condition was used (FHR-1:factor H ratio of 0.37:1), FHR-1 and factor H binding was comparable. Again, FHR-1 bound to CRASP-4, but factor H binding was weak ( figure 6B ; note the different scales of the Y-axes). Both FHR-1 and factor H also bound to CRASP-5 under the physiological setting. Increasing FHR-1 concentrations influenced factor H binding; thus, FHR-1 and factor H seem to share the same binding site(s) (figure 6C).
Cofactor activity of factor H bound to CRASPs. Factor H displays cofactor activity when bound to CRASP-1, -2, or 3 [15, 16] . To link binding with regulation, the cofactor activities of factor H bound to various CRASPs were compared. Prominent cofactor activity, demonstrated by the appearance of a 68, a 46, and a 43, was observed for factor H bound to CRASP-1 and -5 ( figure 7A, lanes 1 and 5) . These cleavage products Figure 6 . Binding competition. The indicated complement regulatoracquiring surface proteins (CRASPs) were immobilized on microtiter plates, and the binding of factor H-related protein 1 (FHR-1) and factor H was analyzed by ELISA. Binding of factor H was determined in the absence of FHR-1. On addition of increasing amounts of FHR-1 (molar ratios are shown), binding was visualized with antibody specific for factor H (monoclonal antibody [MAb] B22) or with MAb VIG8, which reacts with the Cterminus of both FHR-1 and factor H. A, CRASP-3. FHR-1 competed with factor H for binding, as indicated by the reduction of factor H-specific MAb B22 reactivity when FHR-1 was added. In addition, the reactivity of MAb VIG8 was increased. The FHR-1:factor H ratio of 0.37:1 reflects the physiological condition. B, CRASP-4. Factor H binding was not affected by the addition of FHR-1. The reactivity of MAb B22 remained constant, and that of MAb VIG8 increased. C, CRASP-5. Factor H bound strongly to CRASP-5, as indicated by the high absorbency. However, when FHR-1 was added, factor H binding decreased, as indicated by the reduction of factor H-specific MAb B22 reactivity, and MAb VIG8 increased. Note the different scales of the Y-axes. appeared at lower levels when factor H was bound to CRASP-2 (lane 2) and -3 (lane 3). Thus, factor H-mediated regulatory activity does directly correlate with the binding intensity of CRASPs.
CRASP-5 binds the host complement regulator factor H, but it also binds FHR-1, which lacks complement regulatory activities. Previously, a cofactor enhancing activity was demonstrated for FHR-1 [25] . Thus, we analyzed how FHR-1 modulates the cofactor activity of CRASP-5-bound factor H. Factor H was bound in the presence of increasing amounts of FHR-1, and cofactor activity was analyzed. FHR-1, which competes with factor H for binding, decreased cofactor activity in a dosedependent manner. Reduced cofactor activity resulting in less C3b cleavage was indicated by the intensity of the a 43 band ( figure 7B ). Quantitative analyses of the degradation product iC3b showed that, at equal molar FHR-1:factor H ratios, degradation was reduced by 21%, and, at a 2:1 ratio, complement inhibition was reduced by 50% (data not shown). Thus, FHR-1 inhibits the regulatory functions of CRASP-5-bound factor H.
DISCUSSION
Borrelia species express different CRASPs, and CRASP surface expression is associated with serum resistance. Here, we have shown that FHR-1, an additional human plasma protein, binds to the surface of intact serum-resistant, but not serum-sensitive, B. burgdorferi strains. Recombinant FHR-1 binds to CRASP-3 (ErpP), -4 (ErpC), and -5 (ErpA). Thus, each CRASP binds at least 2 members of the factor H family: CRASP-3, -4, and -5 bind FHR-1 and factor H, and CRASP-1 and -2 bind factor H and FHL-1. This preference suggests that, on infection, B. burgdorferi acquire simultaneously 3 proteins of the factor H family and that this type of surface decoration facilitates immune escape of the pathogen and survival in the immunocompetent host.
Human FHR-1 and, similarly, mFHR-C and mFHR-E bind to borrelial strain LW2 (figure 1C) [5] . The 100-kDa mFHR-C, the 40-kDa mFHR-E, and mouse factor H bind to intact B. burgdorferi ( figure 1C ). Binding of mouse factor H to CRASPorthologous Erp and OspE proteins has been shown recently [4] . Binding of human and mouse FHR proteins, which seem to be enriched on the borrelial surface ( figure 1C) , suggests a role for human FHRs and mFHRs in immune evasion. Currently, the biological functions of the FHRs are unknown [26, 27] . FHR-1 has a plasma concentration of ∼50 mg/mL, is a constituent of lipoprotein particles, and binds heparin and the central complement components C3b and C3d [9, 11, 22, [28] [29] [30] .
Serum-resistant Borrelia strains express different numbers and combinations of CRASPs. Each CRASP binds at least 2 factor H family proteins and has a preference for 1 host regulator. CRASP-1 preferentially binds factor H, CRASP-2 preferentially binds FHL-1, CRASP-3 and -4 show a preference for Figure 7 . Complement regulatory activity of complement regulator-acquiring surface protein (CRASP)-bound factor H. Panel A shows that attached factor H retains cofactor activity and that this activity correlates with binding intensity. The indicated CRASPs or an unrelated control protein (p65) were immobilized on microtiter plates. Factor H, C3b, and factor I were added, and, after incubation for 15 min at 37؇C, the mixture was separated by SDS-PAGE; C3b degradation fragments were then analyzed by Western blotting. The mobility of the a chain and the b chain of C3 and the cleavage products of the a chain-a 68, a 46, and a 43-are indicated. Panel B shows that factor H-related protein 1 (FHR-1) influences the cofactor activity of factor H bound to CRASP-5 in a dose-dependent manner (molar ratios are shown).
FHR-1, and CRASP-5 binds FHR-1 and factor H at similar levels. These preferences correlate with the inhibitory potential: prominent cofactor activity is observed for factor H attached to CRASP-1 and CRASP-5 (figure 7). FHR-1 lacks cofactor activity (data not shown) but competes with factor H for binding to 3 CRASPs and thereby inhibits the complement regulatory activity of factor H. When FHR-1 is present in 2-fold molar excess to factor H, complement inactivation is reduced by 50%. Thus, local expression and distribution of the 2 regulators does clearly affect complement inactivation. It has been reported previously that, in fluid phase, FHR-1 enhances cofactor activity of factor H [25] . Although both regulators bind to CRASP-5, CRASP-5-bound FHR-1 lacks complement enhancing activity but shows an inhibitory role. Because FHR-1 negatively affects the complement inhibitory activity of factor H, Borrelia species, which express multiple factor H-binding proteins, may have an advantage on contact with plasma. Thus, because FHR-1 modulates the complement regulatory activity, surface decoration with various host regulatory proteins influences C3b inactivation and immune evasion.
An increasing number of human pathogens are being identified that express surface molecules that bind host complement regulators of the factor H protein family (i.e., factor H, FHL-1, and FHR-1). In addition to B. burgdorferi and B. garinii, gram-positive Streptococcus pyogenes and S. agalacticae bind factor H via the bacterial surface proteins streptococcal M, Fba, and b protein [31, 32] , and S. pneumonia does so via the PspC and Hic surface proteins [33, 34] . In the gram-negative bacteria Neisseria gonorrhoeae and B. hermsii, the Por1A and Fhba protein have been identified [35, 36] . It was recently shown that Treponema denticula bind FHL-1 [37] . For several proteins, the factor H and/or FHL-1 binding sides have been mapped either to the C-terminus (e.g., b protein; CRASP-1, -3, and -5; and the OspE paralogs p21, ErpA, and ErpC) or the N-terminus (e.g., M5, M6, Fba, PspC, and Hic) [27] .
In summary, we have identified human FHR-1 as well as mFHR-C and mFHR-E as additional host plasma proteins that bind to the surface of borrelia. Binding of human FHR-1 is mediated by 3 CRASPs (CRASP-3 [ErpP], -4 [ErpC], and -5 [ErpA]). FHR-1 seems to be relevant for immune evasion of the pathogen, given that FHR-1 competes with factor H for binding and thus modulates the regulatory activity of factor H in complement control. Apparently by decorating its surface with distinct host proteins, the pathogen can modulate and fine-tune its immune escape during infection and in different hosts.
